Company intelligence / Profile preview

Kypha

St. Louis, Missouri, United Stateskypha.net ↗

Ownership: Private
Development stage: Commercial

Overview

Kypha has developed rapid, quantitative platforms for measuring complement activation and cytokine release from biological samples. Their solutions enable earlier and more informed clinical research decisions and patient management in autoimmune/inflammatory disease. The CompAct® Test was advancing toward FDA clearance as of the last update. No direct drug or therapeutic clinical results reported.

Therapeutic areas: Immunology
Modalities: DeviceDiagnostic testPlatform technology (for immune monitoring)
Industry: Protein Biomarker Diagnostics

Partnerships

Extensive network with biopharma companies and clinical collaborators across multiple specialties; specific partners not named but includes relationships with AstraZeneca, Bristol Myers Squibb, Novartis via sponsored research agreements involving key scientific advisors.

Beyond the preview

Go deeper on Kypha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kypha.

Explore the full profile